FDA Approved: LANREOTIDE ACETATE — Original Application (Cipla USA Inc.)

View source ↗

Summary

The FDA approved lanreotide acetate from Cipla USA Inc. as an original application, providing a generic option for the somatostatin analog used in treating acro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly
• Gastroenteropancreatic Neuroendocrine Tumor

Drugs mentioned

• LANREOTIDE ACETATE (Lanreotide acetate)

Snippet

ORIG AP for LANREOTIDE ACETATE (LANREOTIDE ACETATE)